New US Lab Panel Targets Hard-to-Diagnose Liver Fluke Infections
The 3-test panel detects antibodies for parasitic infections that affect up to 45 million people globally and are linked to bile duct cancer.
Read MorePosted by CLP Edit Staff | Feb 11, 2026 | Infectious Diseases |
The 3-test panel detects antibodies for parasitic infections that affect up to 45 million people globally and are linked to bile duct cancer.
Read MorePosted by CLP Edit Staff | Feb 10, 2026 | Histology |
PathAI has launched new AI-powered tools on its AISight Clinical Trials Platform, providing standardized histopathology endpoints for inflammatory bowel disease drug development.
Read MorePosted by CLP Edit Staff | Feb 9, 2026 | Flu & Respiratory Infections |
Visby Medical and Watchmaker Genomics have partnered to develop at-home PCR respiratory tests designed to overcome molecular inhibitors found in unprocessed clinical samples, according to a joint announcement.
Read MorePosted by CLP Edit Staff | Feb 9, 2026 | Hematology Instrumentation |
The test uses miniaturized electrophoresis technology designed to enable decentralized access to quantitative hemoglobin data.
Read MorePosted by CLP Edit Staff | Feb 6, 2026 | Cancer, Diagnostic Technologies, Lab Management |
New Labcorp survey of 152 oncologists reveals 89% expect care to become more complex within three years, while digital integration and coverage barriers persist.
Read More